Cassava Technologies falls after record day, boost from analysts

2020-09-16

  Nasdaq:SAVA fell nearly 10% on Tuesday after rising nearly 90% earlier this week. Analysts raised their ratings after SAVA announced positive news about its Alzheimer’s clinical trial. NASDAQ:SAVA retreated Tuesday after nearly doubling in price on Monday, after Wall Street analysts were bullish on the biotech’s Phase 2B clinicalRead More →